The University of Chicago Header Logo

Connection

Walter M. Stadler to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Radiopharmaceuticals.
Walter M. Stadler
Connection Strength
0.032
Radiopharmaceuticals
  1. Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial. Oncotarget. 2016 10 18; 7(42):69014-69023.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.